Estimating the financial burden of asthma among young adults in Sweden
Asthma in Sweden is associated with a substantial financial burden from both direct costs and asthma-related sick leave compared to matched controls, and the pooled excess burden of ICS-treated asthma in young adults exceeded €200,000,000 annually.
Authors
- Anders Løkke (ORCID: https://orcid.org/0000-0002-6905-4141)
- Ole Hilberg (ORCID: https://orcid.org/0000-0002-3075-3463)
- Kjell Erik Julius Håkansson (ORCID: https://orcid.org/0000-0001-5804-0740)
- Ulla Møller Weinreich (ORCID: https://orcid.org/0000-0003-1975-3654)
- Alma Holm Rovsing
- Rikke Ibsen (ORCID: https://orcid.org/0000-0002-9008-429X)
- Vibeke Backer (ORCID: https://orcid.org/0000-0002-7806-7219)
- Christer Janson
- Charlotte Suppli Ulrik
- Richard Ssegonja
Institutions
- Uppsala University (SE)
- University of Copenhagen (DK)
- University of Southern Denmark (DK)
- Aalborg University Hospital (DK)
- Bispebjerg Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Littlemore Hospital (GB)
- Bodmin Hospital (GB)
Publication Details
- Journal
- European Clinical Respiratory Journal
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1080/20018525.2025.2569135
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca